Neoadjuvant PD-1 Blockade in Resectable Lung CancerPatrick M. Forde, Drew M. Pardoll, Suzanne L. Topalian et al.|New England Journal of Medicine|2018Cited by 2.1k
Genome-wide cell-free DNA fragmentation in patients with cancerStephen Cristiano, Victor E. Velculescu, Alessandro Leal et al.|Nature|2019Cited by 1.5k
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung CancerValsamo Anagnostou, Victor E. Velculescu, Kellie N. Smith et al.|Cancer Discovery|2016Cited by 897
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)Tricia R. Cottrell, Janis M. Taube, Elizabeth D. Thompson et al.|Annals of Oncology|2018Cited by 588
Detection and characterization of lung cancer using cell-free DNA fragmentomesDimitrios Mathios, Victor E. Velculescu, Jakob Sidenius Johansen et al.|Nature Communications|2021Cited by 458